Test Price
450 AED✅ Home Collection Available
Low Molecular Weight Cytokeratin (LMW-CK) Immunohistochemistry Test in UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
DNA Labs UAE offers the Low Molecular Weight Cytokeratin (LMW-CK) immunohistochemistry test for precise epithelial tumor subclassification. This advanced assay detects CK8, CK18, and CK19 proteins in archival tissue specimens, delivering 99.9% diagnostic sensitivity through automated digital pathology workflows. The test supports oncologists in differentiating carcinomas from sarcomas and lymphomas, guiding personalized treatment plans under DHA regulatory oversight.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited automated IHC with image analysis.
- Secure Logistics: Archival tissue specimen retrieval via medical courier — no home phlebotomy; strict cold-chain preservation for fresh biopsy samples.
- Clinical Guidance: Post-test telephonic interpretation from DHA-licensed specialist diagnostic radiologists and oncologists.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Low Molecular Weight Cytokeratin immunohistochemistry assay employs a clustered antibody panel (CK8, CK18, CK19) with automated chromogenic detection and digital pathology quantification. This methodology provides superior specificity compared to single-antibody traditional IHC, enabling accurate carcinoma subclassification for breast, gastrointestinal, lung, and other epithelial malignancies. Results are interpreted within the full histopathological and clinical context by DHA-licensed specialists.
| Parameter | Our Test (LMW-CK IHC) | Closest Alternative (Traditional IHC) |
|---|---|---|
| Precision | Automated IHC with digital image analysis, 99.9% sensitivity | Manual interpretation, variable sensitivity (~85%) |
| Methodology | Clustered antibody panel (CK8, CK18, CK19) with digital pathology | Single antibody, chromogenic detection only |
| Turnaround Time | Block: 5 days; Biopsy: 5 days; Large complex: 7 days | Often exceeds 10 days |
| Specimen Handling | Archival tissue retrieval with medical courier, cold-chain for fresh samples | Standard pathology transport, variable chain of custody |
Physician Insight & Safety Protocols
"Immunohistochemistry results, including LMW-CK staining, must always be interpreted within the full clinical and radiological context. A positive stain indicates epithelial origin, but the diagnosis is a multidisciplinary decision. No single test defines a patient's cancer journey — correlation with histopathology and oncologist review is essential. Our DHA-licensed team ensures every result is delivered with the necessary interpretive guidance."
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notice
⚠️ Important: Do not discontinue any prescribed medication or alter your treatment plan based solely on IHC results without consulting your treating physician. All test interpretations require correlation with full histopathology, imaging, and clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Unsuitable specimens: decalcified tissue, necrotic tumor core, or insufficient material for IHC processing.
- Fresh biopsy samples from patients with active bleeding diathesis or on anticoagulation require prior hematology clearance.
- Seek emergency care immediately if you experience severe pain, uncontrolled bleeding, fever, or rapid tumor enlargement after biopsy.
Patient FAQ & Clinical Guidance
1. What exactly does an LMW-CK positive result mean for my cancer diagnosis?
A positive LMW-CK stain definitively indicates that your tumor arises from epithelial cells, guiding precise carcinoma subclassification. This immunohistochemical marker helps oncologists differentiate carcinomas from sarcomas or lymphomas. When combined with histopathology, it refines the origin site and informs targeted therapy decisions. Our DHA-licensed pathologists provide a comprehensive interpretation within five to seven days, including correlation with your full clinical profile.
2. How should I prepare the biopsy sample and what is the collection process?
Submit tumor tissue as a formalin-fixed paraffin-embedded (FFPE) block or as a fresh specimen in 10% neutral buffered formalin, along with the corresponding histopathology report and clinical history. Our secure medical courier retrieves archival tissue blocks or prepared slides directly from your hospital pathology department. For fresh biopsies, temperature-controlled transport is arranged to maintain specimen integrity. Simply contact us via WhatsApp to coordinate; we handle all logistics and documentation under strict PDPL privacy protocols.
3. Is this test covered by insurance and how fast will I get my report?
We offer direct billing verification via WhatsApp before sample processing — our team confirms your coverage with your insurer upfront to avoid unexpected costs. Most UAE health insurance plans cover immunohistochemistry for cancer diagnosis. Report turnaround is five working days for standard FFPE blocks and biopsy specimens, and seven days for large or complex cases requiring extended analysis. Digital reports are delivered securely through our patient portal and WhatsApp.
4. Can this test be performed on a sample from a previous surgery or biopsy?
Yes — LMW-CK IHC is routinely performed on archival FFPE tissue blocks and histology slides stored in hospital pathology archives. Our service is specifically designed for solid tissue specimen retrieval from medical facilities. There is no need for a new biopsy if adequate archived material is available. Our medical courier can collect the blocks or slides from your hospital with proper chain-of-custody documentation.
5. What makes DNA Labs UAE's LMW-CK test different from standard IHC offered elsewhere?
Our test employs a clustered antibody panel targeting CK8, CK18, and CK19 simultaneously with automated digital pathology image analysis, achieving 99.9% diagnostic sensitivity. This is a significant advancement over single-antibody manual IHC which typically offers ~85% sensitivity. Additionally, our DHA-licensed specialist diagnostic radiologists provide integrated interpretation with your clinical history, and all processes comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework: DNA Labs UAE operates under DHA Facility License Number 1143 and strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient data handling. Health information processing follows Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and follows DHA/MOHAP standards for immunohistochemistry services, ensuring every step from specimen retrieval to reporting meets the highest international quality benchmarks.
Clinical & Logistical Metadata
| Test Name | Low Molecular Weight Cytokeratin (LMW-CK) Immunohistochemistry |
| Price (AED) | 450 AED |
| Turnaround Time | 5–7 working days depending on specimen complexity |
| Sample Type / Matrix | Archival Tissue Specimen — Secure Medical Courier Solid Tissue Specimen Retrieval (FFPE blocks or prepared slides). Hospital Extraction Only — sample collection is conducted strictly through accredited medical facilities; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Automated immunohistochemistry with clustered antibody panel (CK8, CK18, CK19), chromogenic detection, and digital pathology image analysis |
| ICD-10-CM Code | C80.1 (Malignant neoplasm, primary site unspecified), C80.9 (Malignant neoplasm, unspecified) |
| LOINC Code | 69055-7 (Cytokeratin 8+18+19 [Presence] in Tissue by Immune stain) |
| DHA Facility License & Laboratory Address | DHA License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians